BALL KRISTINE M

SEC Form 4 insider trading activity

BALL KRISTINE M has filed 1 SEC Form 4 filing (7 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 14, 2026.

On the most recent filing, BALL KRISTINE M is listed as Director at Oruka Therapeutics, Inc. Inside the rolling window, BALL KRISTINE M reported no open-market purchases and 1 open-market sale totaling $1.9M in ORKA.

Companies traded

Other insiders at ORKA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.9M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ORKASale$1.9MNov 14SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has BALL KRISTINE M made?

BALL KRISTINE M has filed 1 SEC Form 4 filing (7 transaction rows) across 1 company since 2026.

Which companies does BALL KRISTINE M trade?

BALL KRISTINE M has filed SEC Form 4 disclosures for 1 company, including ORKA.

When was BALL KRISTINE M's most recent SEC Form 4 filing?

BALL KRISTINE M's most recent SEC Form 4 filing on Tracefour is dated Nov 14, 2026.

What is BALL KRISTINE M's total buy and sell value in the current window?

Inside the rolling retention window, BALL KRISTINE M bought $0 and sold $1.9M based on SEC Form 4 filings.

What was BALL KRISTINE M's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 18,000 ORKA shares on 2026-11-12, worth $1.9M, per SEC Form 4 filings.